Home > Insider Trading > Filing (0001235802-17-000173)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371217	Reshape Lifesciences Inc.	RSLS	Electromedical & Electrotherapeutic Apparatus (3845)	481293684

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1642607	Y Michael Mashaal	2800 Patton Road St. Paul MN 55113		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value Per Share	Acquisiton	2017-12-19	2,048,700	$0.00	2,617,077	No	4	C	Indirect	See footnote
Series C Convertible Preferred Stock, $0.01 Par Value	Disposition	2017-12-19	20,487	$0.00	26,200	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

Each share of Series C Convertible Preferred Stock converted into 100 shares of common stock.
Consists of shares held directly by HealthCor Partners Fund II, L.P. ("HCPII"). The shares held by HCPII may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCP2LP. Dr. Mashaal is a managing director of HealthCor Partners Management, L.P. ("HCP Management"), which is the investment manager to HCPII, and may be deemed to have shared voting and investment power over such shares. Each of HCPLP, HCP2LP, HCPGP, HCP Management and Dr. Mashaal hereby disclaims any beneficial ownership of shares held by HCPII except to the extent of any pecuniary interest therein.